An "Omic" Overview of Fragile X Syndrome

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Fragile X syndrome (FXS) is a leading genetic cause of neurodevelopmental disorders, characterized by cognitive, behavioral, and medical issues.
• FXS stems from the silencing of the fragile X mental retardation 1 (FMR1) gene, leading to the absence of the crucial FMRP protein.
• FMRP, an RNA-binding protein, is primarily known for its role in regulating translation, and its absence is linked to FXS pathophysiology.

Purpose of the Study:

• To review the multifaceted roles of FMRP beyond its function as a translational regulator.
• To explore novel molecular mechanisms involving FMRP that contribute to the biochemical alterations seen in FXS.
• To provide a comprehensive understanding of FXS pathophysiology by considering diverse FMRP functions.

Main Methods:

• Comprehensive literature review of pre-clinical and clinical studies on FMRP and FXS.
• Analysis of research focusing on FMRP's molecular functions and their implications in FXS.
• Synthesis of data to connect FMRP's diverse roles to the broader biochemical landscape of FXS.

Main Results:

• Pre-clinical studies targeting FMRP's translational regulation successfully ameliorated FXS phenotypes in animal models.
• Clinical trials based on these findings yielded disappointing results, indicating a gap in understanding FXS mechanisms.
• Emerging evidence suggests FMRP has functions beyond translational regulation that are critical for FXS pathophysiology.

Conclusions:

• The failure of translation-focused therapies highlights the need to explore FMRP's broader molecular roles in FXS.
• A comprehensive understanding of FMRP's diverse functions is essential for developing effective therapeutic strategies for FXS.
• This review underscores the importance of investigating novel molecular mechanisms to fully elucidate FXS pathogenesis.